These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10878252)

  • 1. Ligand-protein interactions in nuclear receptors of hormones.
    Egea PF; Klaholz BP; Moras D
    FEBS Lett; 2000 Jun; 476(1-2):62-7. PubMed ID: 10878252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional control: how nuclear receptors get turned on.
    Schwabe JW
    Curr Biol; 1996 Apr; 6(4):372-4. PubMed ID: 8723335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited proteolysis for assaying ligand binding affinities of nuclear receptors.
    Benkoussa M; Nominé B; Mouchon A; Lefebvre B; Bernardon JM; Formstecher P; Lefebvre P
    Recept Signal Transduct; 1997; 7(4):257-67. PubMed ID: 9633826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human nuclear receptor heterodimers: opportunities for detecting targets of transcriptional regulation using yeast.
    Butt TR; Walfish PG
    Gene Expr; 1996; 5(4-5):255-68. PubMed ID: 8723391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones.
    Song C; Hiipakka RA; Kokontis JM; Liao S
    Ann N Y Acad Sci; 1995 Jun; 761():38-49. PubMed ID: 7625741
    [No Abstract]   [Full Text] [Related]  

  • 8. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraspiracle: an invertebrate nuclear receptor for juvenile hormones.
    Jones G; Sharp PA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13499-503. PubMed ID: 9391054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
    Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
    EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digging deep into the pockets of orphan nuclear receptors: insights from structural studies.
    Benoit G; Malewicz M; Perlmann T
    Trends Cell Biol; 2004 Jul; 14(7):369-76. PubMed ID: 15246430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of potential ligands for nuclear receptors in cellular extracts.
    Zeng Z; Allan GF; Thaller C; Cooney AJ; Tsai SY; O'Malley BW; Tsai MJ
    Endocrinology; 1994 Jul; 135(1):248-52. PubMed ID: 8013359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of corepressor binding and release from nuclear hormone receptors.
    Nagy L; Kao HY; Love JD; Li C; Banayo E; Gooch JT; Krishna V; Chatterjee K; Evans RM; Schwabe JW
    Genes Dev; 1999 Dec; 13(24):3209-16. PubMed ID: 10617570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro reporter systems for studying nuclear receptor and ligand activities.
    Mata de Urquiza A; Perlmann T
    Methods Enzymol; 2003; 364():463-75. PubMed ID: 14631861
    [No Abstract]   [Full Text] [Related]  

  • 19. Rational discovery of novel nuclear hormone receptor antagonists.
    Schapira M; Raaka BM; Samuels HH; Abagyan R
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1008-13. PubMed ID: 10655475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
    Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
    EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.